关注
Yasufumi Matsumura
Yasufumi Matsumura
Kyoto University Graduate School of Medicine
在 kuhp.kyoto-u.ac.jp 的电子邮件经过验证
标题
引用次数
引用次数
年份
The global ascendency of OXA-48-type carbapenemases
JDD Pitout, G Peirano, MM Kock, KA Strydom, Y Matsumura
Clinical microbiology reviews 33 (1), 10.1128/cmr. 00102-19, 2019
3792019
Global Escherichia coli sequence type 131 clade with blaCTX-M-27 gene
Y Matsumura, JDD Pitout, R Gomi, T Matsuda, T Noguchi, M Yamamoto, ...
Emerging infectious diseases 22 (11), 1900, 2016
1812016
CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic
Y Matsumura, JR Johnson, M Yamamoto, M Nagao, M Tanaka, ...
Journal of Antimicrobial Chemotherapy 70 (6), 1639-1649, 2015
1382015
Genomic epidemiology of global carbapenemase-producing Enterobacter spp., 2008–2014
G Peirano, Y Matsumura, MD Adams, P Bradford, M Motyl, L Chen, ...
Emerging infectious diseases 24 (6), 1010, 2018
1332018
Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction …
S Nakano, T Fujisawa, Y Ito, B Chang, S Suga, T Noguchi, M Yamamoto, ...
Vaccine 34 (1), 67-76, 2016
1222016
Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan
Y Matsumura, M Yamamoto, M Nagao, G Hotta, A Matsushima, Y Ito, ...
Journal of antimicrobial chemotherapy 67 (11), 2612-2620, 2012
1202012
Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes
Y Matsumura, Y Shindo, Y Iinuma, M Yamamoto, M Shirano, ...
BMC infectious diseases 11, 1-9, 2011
1162011
Quantitative real-time PCR and the (1→ 3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization
Y Matsumura, Y Ito, Y Iinuma, K Yasuma, M Yamamoto, A Matsushima, ...
Clinical microbiology and infection 18 (6), 591-597, 2012
1072012
Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia
M Nagao, Y Iinuma, T Saito, Y Matsumura, M Shirano, A Matsushima, ...
Clinical microbiology and infection 16 (12), 1783-1788, 2010
1062010
Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-β-lactamase-producing Escherichia coli bacteremia
Y Matsumura, M Yamamoto, M Nagao, T Komori, N Fujita, A Hayashi, ...
Antimicrobial agents and chemotherapy 59 (9), 5107-5113, 2015
1052015
Rapid identification of different Escherichia coli sequence type 131 clades
Y Matsumura, JDD Pitout, G Peirano, R DeVinney, T Noguchi, ...
Antimicrobial Agents and Chemotherapy 61 (8), 10.1128/aac. 00179-17, 2017
1012017
Accidental exposures to blood and body fluid in the operation room and the issue of underreporting
M Nagao, Y Iinuma, J Igawa, Y Matsumura, M Shirano, A Matsushima, ...
American Journal of Infection Control 37 (7), 541-544, 2009
972009
Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis
JH Ko, CI Kang, P Cornejo-Juárez, KM Yeh, CH Wang, SY Cho, ...
Clinical Microbiology and Infection 25 (5), 546-554, 2019
932019
Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 …
Y Matsumura, M Yamamoto, M Nagao, Y Ito, S Takakura, S Ichiyama
Antimicrobial agents and chemotherapy 57 (10), 4736-4742, 2013
902013
Global molecular epidemiology of IMP-producing Enterobacteriaceae
Y Matsumura, G Peirano, MR Motyl, MD Adams, L Chen, B Kreiswirth, ...
Antimicrobial agents and chemotherapy 61 (4), 10.1128/aac. 02729-16, 2017
842017
Whole-genome analysis of antimicrobial-resistant and extraintestinal pathogenic Escherichia coli in river water
R Gomi, T Matsuda, Y Matsumura, M Yamamoto, M Tanaka, S Ichiyama, ...
Applied and Environmental Microbiology 83 (5), e02703-16, 2017
792017
Detection of extended-spectrum-β-lactamase-producing Escherichia coli ST131 and ST405 clonal groups by matrix-assisted laser desorption ionization–time of flight mass spectrometry
Y Matsumura, M Yamamoto, M Nagao, M Tanaka, K Machida, Y Ito, ...
Journal of clinical microbiology 52 (4), 1034-1040, 2014
742014
Genomic epidemiology of global VIM-producing Enterobacteriaceae
Y Matsumura, G Peirano, R Devinney, PA Bradford, MR Motyl, MD Adams, ...
Journal of Antimicrobial Chemotherapy 72 (8), 2249-2258, 2017
702017
Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species
G Hotta, Y Matsumura, K Kato, S Nakano, T Yunoki, M Yamamoto, ...
PLoS One 9 (11), e112208, 2014
702014
Characteristics of carbapenemase-producing Enterobacteriaceae in wastewater revealed by genomic analysis
R Gomi, T Matsuda, M Yamamoto, PH Chou, M Tanaka, S Ichiyama, ...
Antimicrobial agents and chemotherapy 62 (5), 10.1128/aac. 02501-17, 2018
662018
系统目前无法执行此操作,请稍后再试。
文章 1–20